InspireMD, Inc.
NSPR
$2.46
-$0.015-0.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.13% | -59.26% | -60.70% | -45.88% | -36.44% |
| Total Depreciation and Amortization | 37.80% | 25.61% | 20.69% | 18.22% | 17.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.37% | 52.43% | 121.98% | 165.16% | 236.76% |
| Change in Net Operating Assets | 842.34% | 298.43% | 191.89% | -53.27% | 49.63% |
| Cash from Operations | -67.68% | -54.11% | -33.54% | -25.34% | -7.19% |
| Capital Expenditure | -69.93% | -184.21% | -267.98% | -400.38% | -150.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -66.67% | -66.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.63% | 173.05% | 189.32% | 147.54% | 214.47% |
| Cash from Investing | -43.97% | 160.58% | 178.55% | 135.85% | 205.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.87% | -52.51% | -53.76% | -57.66% | -57.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 97.78% | 98.25% | 100.00% | 100.00% |
| Cash from Financing | -81.85% | -49.49% | -50.84% | -55.00% | -52.30% |
| Foreign Exchange rate Adjustments | 336.73% | 365.00% | 187.93% | 133.85% | -122.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.21% | -41.99% | 85.22% | -80.02% | 226.86% |